Skip to main content
SpringerLink
Log in

Extended RAS/RAF testing cost effective in mCRC

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Al-hajeili MR, et al. Cost-effectiveness for extended RAS/RAF testing in metastatic colorectal cancer. 51st Annual Meeting of the American Society of Clinical Oncology : abstr. 3572, 29 May 2015. Available from: URL: http://abstracts.asco.org/156/AbstView_156_148840.html

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Extended RAS/RAF testing cost effective in mCRC. PharmacoEcon Outcomes News 732, 18 (2015). https://doi.org/10.1007/s40274-015-2284-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2284-6

Search

Navigation